Aurora Cannabis (ACB) | Financial Analysis & Statements
Aurora Cannabis Inc. Micro-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
94.2M
Gross Profit
46.6M
49.50%
Operating Income
2.2M
2.32%
Net Income
-1.9M
-2.02%
EPS (Diluted)
$0.03
Balance Sheet Metrics
Total Assets
775.3M
Total Liabilities
207.5M
Shareholders Equity
567.8M
Debt to Equity
0.37
Cash Flow Metrics
Operating Cash Flow
18.4M
Free Cash Flow
11.0M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Aurora Cannabis Income Statement From 2020 to 2025
| Metric | 2025 | 2024 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 343.3M | 270.3M | 221.3M | 245.3M | 268.7M |
| Cost of Goods Sold | 155.7M | 138.8M | 200.1M | 266.8M | 288.6M |
| Gross Profit | 187.6M | 131.5M | 21.2M | -21.6M | -19.9M |
| Gross Margin % | 54.6% | 48.6% | 9.6% | -8.8% | -7.4% |
| Operating Expenses | |||||
| Research & Development | 3.7M | 3.6M | 10.4M | 11.4M | 26.0M |
| Selling, General & Administrative | 166.5M | 156.9M | 189.0M | 194.9M | 345.8M |
| Other Operating Expenses | -1.6M | -14.0M | -7.4M | -30.4M | 2.4M |
| Total Operating Expenses | 168.6M | 146.4M | 192.0M | 175.9M | 374.2M |
| Operating Income | 10.0M | -27.1M | -219.4M | -246.6M | -461.7M |
| Operating Margin % | 2.9% | -10.0% | -99.1% | -100.6% | -171.8% |
| Non-Operating Items | |||||
| Interest Income | 11.5M | 12.8M | 4.5M | 5.7M | 5.9M |
| Interest Expense | 8.4M | 14.2M | 71.8M | 66.4M | 76.1M |
| Other Non-Operating Income | 7.3M | -31.1M | -1.4B | -392.5M | -2.8B |
| Pre-tax Income | 20.4M | -59.6M | -1.7B | -699.8M | -3.3B |
| Income Tax | 4.6M | -554.0K | -2.1M | -6.3M | -82.2M |
| Effective Tax Rate % | 22.7% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | 1.6M | -69.3M | -1.7B | -695.1M | -3.3B |
| Net Margin % | 0.5% | -25.6% | -776.2% | -283.4% | -1,231.6% |
| Key Metrics | |||||
| EBITDA | 44.8M | 20.5M | -123.7M | -137.2M | -352.6M |
| EPS (Basic) | $0.04 | $-1.52 | $-79.90 | $-41.00 | $-339.40 |
| EPS (Diluted) | $0.04 | $-1.52 | $-79.90 | $-41.00 | $-339.40 |
| Basic Shares Outstanding | 54832794 | 43223233 | 31226800 | 24572923 | 14171831 |
| Diluted Shares Outstanding | 54832794 | 43223233 | 31226800 | 24572923 | 14171831 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Aurora Cannabis Balance Sheet From 2020 to 2025
| Metric | 2025 | 2024 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 137.9M | 113.4M | 437.8M | 421.5M | 162.2M |
| Short-term Investments | 554.0K | 4.0M | 1.3M | 3.8M | 7.1M |
| Accounts Receivable | 35.0M | 40.5M | 28.7M | 42.0M | 45.2M |
| Inventory | 239.1M | 186.4M | 139.9M | 137.7M | 154.0M |
| Other Current Assets | 10.7M | 9.4M | 6.5M | 11.2M | 22.1M |
| Total Current Assets | 478.3M | 426.6M | 745.1M | 665.9M | 417.5M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 157.9M | 159.3M | 173.9M | 188.0M | 193.1M |
| Goodwill | 132.9M | 127.2M | 70.7M | 2.1B | 2.3B |
| Intangible Assets | 45.2M | 40.8M | 70.7M | 367.4M | 412.3M |
| Long-term Investments | - | 0 | 26.3M | 59.4M | 41.8M |
| Other Non-Current Assets | 17.2M | 33.7M | 7.6M | 4.3M | - |
| Total Non-Current Assets | 374.3M | 412.1M | 339.2M | 1.9B | 2.4B |
| Total Assets | 852.7M | 838.7M | 1.1B | 2.6B | 2.8B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 27.6M | 20.3M | 13.9M | 13.3M | 19.7M |
| Short-term Debt | 26.9M | 57.2M | 33.0M | 40.9M | 152.6M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | 18.6M | 10.9M | 20.0K |
| Total Current Liabilities | 110.9M | 124.6M | 130.9M | 116.4M | 272.3M |
| Non-Current Liabilities | |||||
| Long-term Debt | 77.7M | 47.6M | 236.5M | 358.6M | 378.6M |
| Deferred Tax Liabilities | 1.9M | 16.2M | 2.9M | 0 | 3.9M |
| Other Non-Current Liabilities | 48.1M | 46.1M | 128.0K | 104.0K | 37.0K |
| Total Non-Current Liabilities | 133.2M | 112.2M | 291.1M | 450.7M | 384.4M |
| Total Liabilities | 244.1M | 236.8M | 422.0M | 567.0M | 656.7M |
| Equity | |||||
| Common Stock | 7.0B | 7.0B | 6.8B | 6.4B | 5.8B |
| Retained Earnings | -6.4B | -6.4B | -6.0B | -4.3B | -3.6B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 608.6M | 601.9M | 662.4M | 2.0B | 2.1B |
| Key Metrics | |||||
| Total Debt | 104.6M | 104.8M | 269.5M | 399.6M | 531.2M |
| Working Capital | 367.5M | 302.0M | 614.3M | 549.5M | 145.3M |
Balance Sheet Composition
Aurora Cannabis Cash Flow Statement From 2020 to 2025
| Metric | 2025 | 2024 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 15.8M | -59.0M | -1.7B | -693.5M | -3.3B |
| Depreciation & Amortization | 22.5M | 33.1M | 93.7M | 98.1M | 114.7M |
| Stock-Based Compensation | 11.5M | 12.7M | 13.8M | 20.2M | 59.2M |
| Working Capital Changes | 5.4M | -16.3M | 49.6M | -1.9M | 3.7M |
| Operating Cash Flow | 24.2M | -102.1M | -1.6B | -555.4M | -3.1B |
| Investing Activities | |||||
| Capital Expenditures | -16.8M | -4.7M | -12.6M | -33.8M | -347.6M |
| Acquisitions | 0 | -5.5M | -23.4M | 0 | 27.9M |
| Investment Purchases | - | - | 0 | -6.7M | -2.0M |
| Investment Sales | 5.5M | 5.0M | 0 | 18.1M | 90.8M |
| Investing Cash Flow | -15.6M | -5.2M | -36.2M | -28.4M | -270.6M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 11.7M | 14.5M | 0 | 0 | 88.1M |
| Debt Repayment | -12.5M | -100.3M | -170.8M | -122.9M | -124.0M |
| Financing Cash Flow | -805.0K | -47.8M | 147.8M | 522.3M | 583.9M |
| Free Cash Flow | -2.9M | -85.5M | -142.5M | -263.7M | -691.0M |
| Net Change in Cash | 7.8M | -155.1M | -1.5B | -61.6M | -2.8B |
Cash Flow Trend
Aurora Cannabis Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
20.75
Forward P/E
-30.82
Price to Book
0.49
Price to Sales
0.54
PEG Ratio
-0.22
Profitability Ratios
Profit Margin
-22.51%
Operating Margin
2.32%
Return on Equity
-15.51%
Return on Assets
-4.36%
Financial Health
Current Ratio
3.06
Debt to Equity
17.79
Beta
1.32
Per Share Data
EPS (TTM)
$-1.09
Book Value per Share
$6.92
Revenue per Share
$6.64
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ACB | 200.4M | 20.75 | 0.49 | -15.51% | -22.51% | 17.79 |
| Zoetis | 49.8B | 19.58 | 15.04 | 65.99% | 28.24% | 279.59 |
| Haleon Plc - ADR | 42.4B | 18.72 | 1.88 | 10.27% | 15.11% | 52.37 |
| Anika Therapeutics | 221.7M | - | 1.48 | -6.71% | -9.64% | 18.30 |
| Organigram Holdings | 203.2M | 13.05 | 0.72 | 4.64% | 6.49% | 1.99 |
| Lifecore Biomedical | 184.4M | 56.23 | -17.45 | 312.34% | -23.78% | 414.80 |
Financial data is updated regularly. All figures are in the company's reporting currency.






